Nasmed Ozel Saglik Stock Current Liabilities
| EGEPO Stock | 26.30 0.82 3.02% |
Nasmed Ozel Saglik fundamentals help investors to digest information that contributes to Nasmed Ozel's financial success or failures. It also enables traders to predict the movement of Nasmed Stock. The fundamental analysis module provides a way to measure Nasmed Ozel's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nasmed Ozel stock.
Nasmed |
Nasmed Ozel Saglik Company Current Liabilities Analysis
Nasmed Ozel's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
In accordance with the recently published financial statements, Nasmed Ozel Saglik has a Current Liabilities of 0.0. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Current Liabilities (which currently averages 0.0) industry. This indicator is about the same for all Turkey stocks average (which is currently at 0.0).
Nasmed Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nasmed Ozel's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nasmed Ozel could also be used in its relative valuation, which is a method of valuing Nasmed Ozel by comparing valuation metrics of similar companies.Nasmed Ozel is currently under evaluation in current liabilities category among its peers.
Nasmed Fundamentals
| Return On Equity | 0.0238 | |||
| Return On Asset | 0.0221 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.06 % | |||
| Shares Owned By Insiders | 8.00 % | |||
| Revenue | 229.67 M | |||
| Gross Profit | 40.73 M | |||
| EBITDA | 31.65 M | |||
| Book Value Per Share | 2.45 X | |||
| Earnings Per Share | 0.14 X | |||
| Number Of Employees | 851 |
About Nasmed Ozel Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nasmed Ozel Saglik's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nasmed Ozel using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nasmed Ozel Saglik based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Nasmed Stock
Nasmed Ozel financial ratios help investors to determine whether Nasmed Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nasmed with respect to the benefits of owning Nasmed Ozel security.